论文部分内容阅读
目的：观察决明子散剂的调脂疗效及安全性。方法：将１１４例高脂血症患者，随机分为２组，第１组５７例，服决明子散剂，４ｇ／次，ｂｉｄ．。第２组５７例，服安慰剂胶囊，１粒／次，ｂｉｄ。疗程均为８周。结果：与服药前相比，８周后，决明子散剂组平均血清ＴＣ、ＬＤＬＣ、ＴＧ水平和ＴＣ／ＨＤＬＣ比值分别下降１２．７％、１０．１％、３４．７％、及１５．９％，ＨＤＬＣ升高１１．７％（Ｐ＜０．０５～０．００１）。降低幅度均明显大于安慰剂组（Ｐ均＜０．００１）。未见有临床意义的副作用。结论：决明子散剂是一种安全、有效及易耐受的血脂调节药。
Objective: To observe the efficacy and safety of Cassia seed powder in regulating lipid regulation. Methods: 114 cases of hyperlipidemia patients were randomly divided into two groups, the first group of 57 cases, taking Dingdingzi powder, 4g / time, bid. . Group 2 57 cases, placebo capsules, 1 / time, bid. The course of treatment is 8 weeks. Results: After 8 weeks, the serum levels of TC, LDLC, TG and TC / HDLC in the Cassiaei powder group decreased by 12.7%, 10.1% and 34.7% respectively, and 15.9%, HDL C increased by 11.7% (P <0.05 ~ 0.001). The reduction was significantly greater than placebo (P <0.001). No clinically significant side effects. Conclusion: Cassia powder is a safe, effective and easy to tolerate blood lipid regulating drugs.